Finally, we addressed whether the LPA-promoted signature associated with Hh (GLI1, BMI1) and EMT (SNAI1, TWIST1) genes has an impact on the clinical outcome of ovarian cancer patients. The gene discussed is GLI1; the disease is ovarian cancer.